1-2 of 2
Authors: Takuto Kuramoto
Sort by
Journal Article
A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialysis patients Open Access
Masafumi Fukagawa and others
Nephrology Dialysis Transplantation, Volume 32, Issue 10, October 2017, Pages 1723–1730, https://doi.org/10.1093/ndt/gfw408
Published: 04 January 2017
Journal Article
MP361EFFICACY AND SAFETY OF A NOVEL INTRAVENOUS CALCIMIMETIC, ONO-5163 (ETELCALCETIDE) IN JAPANESE HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM : RESULTS OF A PLACEBO CONTROLLED PHASE III STUDY Free
Masafumi Fukagawa and others
Nephrology Dialysis Transplantation, Volume 31, Issue suppl_1, May 2016, Page i460, https://doi.org/10.1093/ndt/gfw190.18
Published: 14 May 2016
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals